Chemotherapy of epithelial ovarian cancer: CHexUP versus thio-tepa
Wu, B.Z.
Zhonghua Fu Chan Ke Za Zhi 22(1): 5-8; 61
1987
ISSN/ISBN: 0529-567X PMID: 3109851 Document Number: 289649
Document emailed within 1 workday
Related Documents
Neĭshtadt, E.L.; Gnilevskaia, Z.U.; Aĭnbinder, N.M. 1975: Chromosomal aberrations induced by thio-TEPA in cells of malignant ovarian tumors in humans Voprosy Onkologii 21(7): 48-53Chauvergne, J.; Hoerni, B.; Hoerni-Simon, G.; Durand, M. 1973: The combination of thio-tepa and 5 fluorouracil as a palliative therapy for breast cancer Revue Francaise de Gynecologie et d'Obstetrique 68(3): 159-165
Drukin, E.I.; Smirnov, A.D.; Berlin, L.B. 1970: Effect of cystamine on cytogenetic changes in bone marrow cells and lymphocytes of the peripheral blood in patients with bronchial cancer treated with thio-TEPA Klinicheskaia Meditsina 48(12): 48-52
Wang, J.; Li, A.J.; Karlan, B.Y. 2002: Chemotherapy in epithelial ovarian cancer Current Women's Health Reports 2(1): 20-26
Hatae, M.; Onishi, Y.; Maeda, Y.; Nakamura, T.; Maeda, T.; Wada, T. 1995: Consensus and new development in epithelial ovarian cancer chemotherapy in 1995 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(9): 1182-1189
Satthapong, D.; Tangjitgamol, S.; Manusirivithaya, S.; Pataradool, K. 2007: Chemotherapy in patients with recurrent or refractory epithelial ovarian cancer Journal of the Medical Association of Thailand 90(3): 411-419
Misawa, H.; Ochiai, K.; Yasuda, M.; Tanaka, T. 2004: Combination chemotherapy with docetaxel and carboplatin for epithelial ovarian cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 10): 546-549
Combiescu, I.; Enescu, A.; Balazs, D. 1971: The temperature factor in Thio-tepa chemosterilization of Musca domestica L Archives Roumaines de Pathologie Experimentales et de Microbiologie 30(3): 445-448
Venesmaa, P. 1994: Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990 Obstetrics and Gynecology 84(1): 8-11
Pankov, A.K.; Smiller, R.R.; Il'inskaia, E.G.; Shurygina, E.A. 1973: Functional state of the adrenal cortex in malignant tumors of the ovaries during thio-TEPA treatment Voprosy Onkologii 19(4): 31-35
Kietpeerakool, C.; Tiyayon, J.; Suprasert, P.; Kanjanavanit, R.; Srisomboon, J. 2006: Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer Journal of the Medical Association of Thailand 89(11): 1805-1810
Tanaka, N.; Matsui, H.; Nagai, Y.; Suzuka, K.; Seki, K.; Sekiya, S. 2002: Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer European Journal of Gynaecological Oncology 23(4): 281-286
Kotz, K.W.; Schilder, R.J. 1995: High-dose chemotherapy and hematopoietic progenitor cell support for patients with epithelial ovarian cancer Seminars in Oncology 22(3): 250-262
Stetsenko, D.V. 1972: The effect of the drug thio-TEPA on the microbial flora of the urine of patients with urinary bladder neoplasms Klinicheskaia Khirurgiia 10: 82
Tanaka, H.; Umekawa, T.; Nagao, K.; Ishihara, A.; Toyoda, N. 2003: Salvage chemotherapy with a combination of irinotecan hydrochloride and mitomycin C in platinum- and paclitaxel-resistant epithelial ovarian cancer: case reports European Journal of Gynaecological Oncology 24(3-4): 337-340
Mukaiyama, T.; Ogawa, M.; Horikoshi, N.; Inoue, K.; Aiba, K.; Matsuoka, A.; Matsumura, T.; Ogihara, A.; Sumida, T. 1992: High-dose thio-TEPA with escalating doses of epirubicin and autologous hematopoietic stem cell transplant for refractory cancers Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(2): 189-194
Akilli, H.; Rahatli, S.; Tohma, Y.A.; Karakas, L.A.; Altundag, O.; Ayhan, A. 2018: Effect of increased number of neoadjuvant chemotherapy cycles on tumor resectability and pathologic response in advanced stage epithelial ovarian cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 23(7): 111-115
Vapattanawong, P. 2006: A comparative study on hematological effects of carboplatin plus cyclophosphamide and carboplatin plus paclitaxel chemotherapy for the first line treatment of epithelial ovarian cancer Journal of the Medical Association of Thailand 89(9): 1357-1361
Nishikawa, A.; Hashimoto, H.; Takeda, M.; Kontani, K.; Miyatake, T.; Mimura, M.; Nagamatsu, M.; Yokoi, T. 2016: Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy European Journal of Gynaecological Oncology 37(4): 451-454
Bertucci, F.; Viens, P.; Gravis, G.; Blaise, D.; Faucher, C.; Oziel-Taoeb, S.; Bardou, V.J.; Jacquemier, J.; Delpero, J.R.; Maraninchi, D. 1999: High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: analysis of 67 patients treated in a single institution Anticancer Research 19(2b): 1455-1461